Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 9/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.50 |
| ▸ | KCNQ3 | O43525 | 2/20 | 0.44 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.44 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.44 |
| ▸ | KCNQ1 | P51787 | 2/20 | 0.44 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL628210 | 0.85 | CCR2 (0.49) | CCR2KCNH2 | |
| SCHEMBL629462 | 0.83 | CCR2 (0.64) | CCR2KCNH2 | |
| SCHEMBL628232 | 0.83 | CCR2 (0.49) | CCR2KCNH2CCNA2CDK2CCNA1 | |
| SCHEMBL629409 | 0.82 | CCR2 (0.53) | CCR2KCNH2 | |
| SCHEMBL627758 | 0.81 | CCR2 (0.49) | CCR2KCNH2CCNA2CDK2CCNA1 | |
| SCHEMBL12342237 | 0.80 | CCR2 (0.79) | CCR2KCNH2 | |
| SCHEMBL3461235 | 0.80 | CCR2 (0.79) | CCR2KCNH2 | |
| SCHEMBL627793 | 0.79 | CCR2 (0.65) | CCR2KCNH2 | |
| SCHEMBL3721562 | 0.79 | CCR2 (0.50) | CCR2KCNH2 | |
| SCHEMBL633107 | 0.79 | CCR2 (0.51) | CCR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2419417-A1 | 4-AZETIDINYL-1-HETEROARYL-CYCLOHEXANE ANTAGONISTS OF CCR2 | Janssen Pharmaceutica, N.V. (BE) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010121011-A1 | 4-AZETIDINYL-1-HETEROARYL-CYCLOHEXANE ANTAGONISTS OF CCR2 | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-21 | — | — | WO | disclosed |